Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...
Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy ...
Policy changes, such as banning spread pricing and promoting transparency, are necessary to realign the pharmacy benefit manager (PBM) market and ensure that health care resources benefit patients and ...
As pharmacy benefit managers (PBMs) come under increased scrutiny from regulatory agencies, here are 5 things to know about their role in the health care system. Pharmacy benefit managers (PBMs), ...
NEW YORK, NEW YORK - JULY 23: Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024 in New York City. A major issue in the presidential race between both parties is ...
On Monday, a state-funded committee in Louisiana gave Mark Cuban’s Cost Plus Drug Company a taxpayer-funded microphone to attack Pharmacy Benefit Managers (PBMs). But what the public was not made ...
Few healthcare entities are as maligned as pharmacy benefit managers (PBMs). These so-called industry middlemen have garnered significant negative attention for accusations that they drive up ...
As employers, choosing the right partner to manage health benefits and coverage is one of the most significant decisions you'll make for the organization as a whole. Beyond influencing spend, the ...
The new law requiring pharmacy benefit managers to explain prescription drug costs could impact a key factor in retirement readiness. The recently passed appropriations package, which ended a brief ...
The Department of Labor wants to force pharmacy benefit managers to share more information about their compensation and business practices with their employer clients, in the latest bet from the Trump ...
Morgan Harper is the director of policy and advocacy and Emma Freer is a senior policy analyst at the American Economic Liberties Project. “I don't know what some of the (patients) are going to do,” a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results